421
Participants
Start Date
September 30, 2016
Primary Completion Date
July 31, 2017
Study Completion Date
October 31, 2017
AllerT
Bet v 1 contiguous overlapping peptides mixed with aluminium hydroxide solution
placebo
placebo
Ski Ore-Nese-Hals, Ski
Harestua Medisinske Senter, Harestua
Herlev-Gentofte Hospital, Hud - og Allergiafdelingen,, Hellerup
Næstved Sygehus, Lungemedicinsk avd, Næstved
Odense Universitetshospital, Odense
Kolding Hospital, Kolding
Lungemedicinsk Forskningsafdeling,, Aarhus
Vilnius City Clinical hospital, Vilnius
Karolinska Trial Alliance, Stockholm
HNO Heilkunde u. Allergologie praxis, Berlin
TYKS T-sairaala Allergiayksikkö TA2, Turku
Grazyna Pulka Specjalistyczny Osradek All-Med, Krakow
Malopolskie Centrum Alergologii, Krakow
EMED Centrum Uslug Medycznych, Rzeszów
HNO Praxis Dr Thieme, Duisburg
Hospital of Lithuanian University, Kaunas
CD8 Klinika, Kaunas
All-Med Specjalistyczna Opieka Medyczna, Wroclaw
NZOZ-ALER-med Specjalistyczna Opieka Medycna, Wroclaw
Zentrum fur Rhinologie une Allergologie, Wiesbaden
HNO Praxis Dr Horn, Heidelberg
Dres Heimlich HNO praxis, Heidelberg
Clinica Vitae, Gdansk
Oulun Yliopistollinen sairaala Korva-, nenä- ja kurkkutautien poliklinikka., Oulu
DANIMED s.r.o. Ambulancia klinickejimunologie a alergologie, Levice
Imunoalergologicka ambulancia, Šurany
Imunologia a alergologia, Komárno
Clinmedica Research OMC, Skierniewice
HNO Praxis Dr Yarin, Dresden
Medamed, Leipzig
Vilnius University Hospital, Vilnius
KAL Kliniken, Oslo
ALIAN s.r.o. Ambulancia alergologie, Bardejov
ALERSA s.r.o. Imunoalergologicka ambulancia, Košice
STALERG s.r.o. Imunoalergologicka ambulancia, Košice
EMED s.r.o. Alergoimunologické centrum, Prešov
Lead Sponsor
Anergis
INDUSTRY